<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182022000301215</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v51n3.100424</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Kollicoat MAE® 100P as a film former polymer for nanoparticles preparation]]></article-title>
<article-title xml:lang="pt"><![CDATA[Kollicoat MAE® 100P como polímero formador de filme para a preparação de nanopartículas]]></article-title>
<article-title xml:lang="es"><![CDATA[Kollicoat MAE® 100P como polímero formador de película para la preparación de nanopartículas]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodrigues Acacio]]></surname>
<given-names><![CDATA[Bianca]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bautista Robles]]></surname>
<given-names><![CDATA[Verónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Prada Lafourcade]]></surname>
<given-names><![CDATA[Ariadna]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Assis]]></surname>
<given-names><![CDATA[Joao Marcos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pereira de Souza]]></surname>
<given-names><![CDATA[Tatiane]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Keita]]></surname>
<given-names><![CDATA[Hady]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Florentino Neto]]></surname>
<given-names><![CDATA[Serafim]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paredes Gamero]]></surname>
<given-names><![CDATA[Edgar Julian]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Amado]]></surname>
<given-names><![CDATA[Jesús Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Federal University of Matogrosso do Sul Faculty of Pharmaceutical Sciences, Food and Nutrition ]]></institution>
<addr-line><![CDATA[Campo Grande MS]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Federal University of Matogrosso do Sul Faculty of Pharmaceutical Sciences, Food and Nutrition ]]></institution>
<addr-line><![CDATA[Campo Grande MS]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Federal University of Amazonas Faculty of Pharmacy ]]></institution>
<addr-line><![CDATA[Manaus AM]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,BASF S.A.  ]]></institution>
<addr-line><![CDATA[São Paulo ]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Federal University of Amazonas Department of Medicines and Food ]]></institution>
<addr-line><![CDATA[Manaus AM]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,University of Sierra Sur  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af7">
<institution><![CDATA[,Federal University of Amazonas  ]]></institution>
<addr-line><![CDATA[Manaus AM]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af8">
<institution><![CDATA[,Universidade Federal do Matogrosso do Sul Faculty of Pharmaceutical Sciences, Food and Nutrition ]]></institution>
<addr-line><![CDATA[Campo Grande MS]]></addr-line>
<country>Brazil</country>
</aff>
<aff id="Af9">
<institution><![CDATA[,Universidade Federal do Matogrosso do Sul Faculty of Pharmaceutical Sciences, Food and Nutrition ]]></institution>
<addr-line><![CDATA[Campo Grande MS]]></addr-line>
<country>Brazil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<volume>51</volume>
<numero>3</numero>
<fpage>1215</fpage>
<lpage>1231</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182022000301215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182022000301215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182022000301215&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Introduction: Until now, few research works have reported the usefulness of Kollicoat MAE® 100P as a film-former polymer for coating nanocapsules and as a matrix former for nanospheres.  Aim: To update the current knowledge about the use of Kollicoat MAE® 100P as a film-former polymeric to prepare gastro-resistant nanoparticles. Physicochemical characteristics and functionality of nanoparticles coated with Kollicoat MAE® 100P were reported.  Methodology: An exhaus tive review was performed (from 1980 to 2021) in various scientific databases like Medline, Scopus, EBSCO and Cambridge.  Results: Kollicoat MAE® 100P is a versatile polymer that can be used to prepare gastro-resistant nanoparticles with actives of natural and synthetic origin. This polymer allows producing homogeneous nanoparticles with sizes smaller than 130 nm, and high z-potential, which confers a great stability to nanoparticle systems. On the other side, nanoparticles coated with Kollicoat MAE® 100P combined with plasticizer exhibit a hard and flexible shell, with excellent thermal stability up to 60 °C that dissolve at pH above 5.5.  Conclu sion: Kollicoat MAE® 100P ris a viable, low-cost, and multifunctional alternative for nanoparticle preparation, however, more studies are needed to develop enhanced nanoparticles with better performances.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução: até hoje, poucas pesquisas têm sido desenvolvidas com o intuito de avaliar a utilidade do Kollicoat MAE® 100P como polímero formador de filme para recobrimento de nanocápsulas e como formador de matriz para preparação de nanoesferas.  Objetivo: atualizar o estado da arte sobre a utilização de Kollicoat MAE® 100P para a preparação de nanopartículas gastrorresistentes, suas caracterís ticas físico-químicas e a funcionalidade das nanopartículas cobertas com Kollicoat MAE® 100P.  Metodologia: foi realizada uma revisão exaustiva (de 1980 a 2021) em várias bases de dados como Medline, Scopus, EBSCO e Cambridge.  Resul tados: Kollicoat MAE® 100P é um polímero versátil, que pode ser utilizado para a preparação de nanopartículas gastrorresistentes carregadas com ativos naturais e sintéticos, com tamanho menor que 130 nm, baja polidispersão e alto potencial z, o que lhe confere grande estabilidade. O Kollicoat MAE® 100P combinadas com plastificantes adequados, produze cobertas duras e flexíveis, com excelente estabili dade térmica até 60 °C, que dissolvem em pH acima de 5,5.  Conclusões: Kollicoat MAE® 100P representa uma alternativa viável, de baixo custo e multifuncional para a preparação de nanocápsulas e nanoesferas gastroresistentes. No entanto, outros estudos são necessários para desenvolver nanoformulações baseadas neste polímero com melhor funcionalidade.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: hasta ahora, pocos trabajos de investigaciones han relatado la utilidad de Kollicoat MAE® 100P como polímero formador de película para el recubrimiento de nanocápsulas y como formador de matriz para preparar nanoesferas.  Objetivo: actualizar el estado del conocimiento sobre las características fisicoquímicas de Kollicoat MAE® 100P, su uso como material formador de películas de cubierta para preparación de nanopartículas gastrorresistentes, y la funcionalidad de las nanopartículas preparadas con este polímero.  Metodología: se realizó una revisión exhaus tiva (de 1980 a 2021) en varias bases de datos como Medline, Scopus, EBSCO y Cambridge.  Resultados: Kollicoat MAE® 100P es un polímero versátil que puede utilizarse para la preparación de nanopartículas gastrorresistentes usando activos naturales y sintéticos. Este polímero produce nanopartículas menores que 130 nm, bajo índice de polidispersión y potencial z relativamente altos, lo que confiere gran estabilidad a formulaciones de nanopartículas. El Kollicoat MAE® 100P, combinado con un plastificante adecuado, produce una cubierta dura y flexible, con excelente estabilidad térmica a temperaturas hasta 60 °C que se disuelve a pH mayores que 5,5.  Conclusión: Kollicoat MAE® 100P es un polímero multifuncional, de bajo costo útil para preparar nanopartículas gastroresistentes. Sin embargo, podrían realizarse otros estudios para desarrollar nanopartículas con mejor funcionalidad.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Kollicoat]]></kwd>
<kwd lng="en"><![CDATA[nanoparticles]]></kwd>
<kwd lng="en"><![CDATA[acrylates]]></kwd>
<kwd lng="en"><![CDATA[gastroresistant]]></kwd>
<kwd lng="pt"><![CDATA[Kollicoat]]></kwd>
<kwd lng="pt"><![CDATA[nanopartículas]]></kwd>
<kwd lng="pt"><![CDATA[acrilatos]]></kwd>
<kwd lng="pt"><![CDATA[gastrorresistente]]></kwd>
<kwd lng="es"><![CDATA[Biotecnología]]></kwd>
<kwd lng="es"><![CDATA[nanomedicina]]></kwd>
<kwd lng="es"><![CDATA[nanomateriales]]></kwd>
<kwd lng="es"><![CDATA[nanocompuestos]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zorzi]]></surname>
<given-names><![CDATA[G.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[E.L.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Poser]]></surname>
<given-names><![CDATA[G.L. Von]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[H.F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[On the use of nanotechnology-based strategies for association of complex matrices from plant extracts]]></article-title>
<source><![CDATA[Rev. Bras. Farmacogn]]></source>
<year>2015</year>
<volume>25</volume>
<page-range>426-36</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Saeed]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanoparticles: Properties, applications, and toxicities]]></article-title>
<source><![CDATA[Arab.]. Chem]]></source>
<year>2019</year>
<volume>12</volume>
<page-range>908-31</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shelake]]></surname>
<given-names><![CDATA[S.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Patil]]></surname>
<given-names><![CDATA[S.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Patil]]></surname>
<given-names><![CDATA[S.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Formulation and evaluation of fenofibrate-loaded nanoparticles by precipitation method]]></article-title>
<source><![CDATA[Indian. J. Pharm. Sci.]]></source>
<year>2018</year>
<volume>80</volume>
<page-range>420-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bajdik]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Pintye-Hodi]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Study of deformation process of stored polymeth-acrylate free film]]></article-title>
<source><![CDATA[Pharmazie]]></source>
<year>2006</year>
<volume>61</volume>
<page-range>887-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[C.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Fessi]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Elaissari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polymer-based nanocapsules for drug delivery]]></article-title>
<source><![CDATA[Int. J. Pharm.]]></source>
<year>2010</year>
<volume>385</volume>
<page-range>113-42</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quintanar]]></surname>
<given-names><![CDATA[G.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Allemann]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Fessi]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Doelker]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preparation tech niques and mechanisms of formation of biodegradable nanoparticles from preformed polymers]]></article-title>
<source><![CDATA[Drug. Dev. Ind. Pharm.]]></source>
<year>1998</year>
<volume>24</volume>
<page-range>1113-28</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schaffazick]]></surname>
<given-names><![CDATA[S.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Guterres]]></surname>
<given-names><![CDATA[S.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[L.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Pohlmann]]></surname>
<given-names><![CDATA[A.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos]]></article-title>
<source><![CDATA[Quim. Nova]]></source>
<year>2013</year>
<volume>26</volume>
<page-range>726-37</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prada]]></surname>
<given-names><![CDATA[A.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Bitencourt]]></surname>
<given-names><![CDATA[A.P.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[A.J.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[R.A.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho, Fernandes]]></surname>
<given-names><![CDATA[J.C.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and characterization of Cassia grandis and Bixa orellana nanoformulations]]></article-title>
<source><![CDATA[Curr. Top. Med. Chem.]]></source>
<year>2016</year>
<volume>16</volume>
<page-range>2057-65</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[A.J.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Prada]]></surname>
<given-names><![CDATA[A.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[J.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Keita]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[H.R. da]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[A.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development, stability and in vitro delivery profile of new loratadine-loaded nanoparticles]]></article-title>
<source><![CDATA[Saudi Pharm. J.]]></source>
<year>2017</year>
<volume>25</volume>
<page-range>1158-68</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehnert]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Mäder]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Solid lipid nanoparticles: Production, characterization and applications]]></article-title>
<source><![CDATA[Adv. Drug Deliv.]]></source>
<year>2001</year>
<volume>47</volume>
<page-range>165-96</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meerovich]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Dash]]></surname>
<given-names><![CDATA[A.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Holban]]></surname>
<given-names><![CDATA[A.-M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mihai-Grumezescu]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Materials for Biomedical Engineering: Organic Micro and Nanostructures]]></source>
<year>2019</year>
<page-range>269-309</page-range><publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schaffazick]]></surname>
<given-names><![CDATA[S.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Pohlmann]]></surname>
<given-names><![CDATA[A.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Guterres]]></surname>
<given-names><![CDATA[S.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanocapsules, nanoemulsion and nanodispersion containing melatonin: Preparation, characterization and stability evaluation]]></article-title>
<source><![CDATA[Pharmazie]]></source>
<year>2007</year>
<volume>62</volume>
<page-range>354-60</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bühle]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<source><![CDATA[Kollicoat grades. "Functional polymers for the pharmaceutical indus try"]]></source>
<year>2007</year>
<volume>67056</volume>
<publisher-name><![CDATA[BASF, Pharma Solutions, Aktiengesellschaft]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<source><![CDATA[Pharma Ingredients &amp; Services Kollicoat® MAE grades ®-Registered trademark of BASF group Methacrylic acid/ethyl acrylate copolymers for enteric coatings]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<source><![CDATA[BASF, Technical information, Methacrylic acids/ethyl acrylates copolymer for enteric coating. Kollicoat MAE® 100P. Pharma Ingredients and service. BASF SE, BASF]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Limburgerhof ]]></publisher-loc>
<publisher-name><![CDATA[The chemical company]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corell]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Bang]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Cech]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Haberecht]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Máder]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Investigating the effect of partial neutralisation of the polymer on the dissolution characteristics of poly (methacrylic acid-co-ethyl acrylate) based coats]]></source>
<year></year>
<conf-name><![CDATA[ 11thWorld Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology]]></conf-name>
<conf-date>2018</conf-date>
<conf-loc>Granada, Spain </conf-loc>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Felton]]></surname>
<given-names><![CDATA[A.L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Boca Raton (FL) ]]></publisher-loc>
<publisher-name><![CDATA[CRC Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lafourcade]]></surname>
<given-names><![CDATA[P.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Achod]]></surname>
<given-names><![CDATA[L.D.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Keita]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[J.C.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[T.P. de]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[A.J.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development, pharmacological and toxicological evaluation of a new tablet formulation based on Cassia grandis fruit extract]]></article-title>
<source><![CDATA[Sustain. Chem. Pharm.]]></source>
<year>2020</year>
<volume>16</volume>
<page-range>100244</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prada]]></surname>
<given-names><![CDATA[A.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Keita]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[T.P. de]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[E.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Acho]]></surname>
<given-names><![CDATA[L.D.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[M.J.A. da]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cassia grandis Lf nanodispersion is a hypoglycemic product with a potent a-glucosidase and pancreatic lipase inhibitor effect]]></article-title>
<source><![CDATA[Saudi Pharm. J.]]></source>
<year>2019</year>
<volume>27</volume>
<page-range>191-9</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hossain]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Jalil]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Reza]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Quadir]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Hossain]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of Kollicoat SR 30D and Kollicoat EMM 30D as matrix former for controlled release drug delivery]]></article-title>
<source><![CDATA[Dhaka Univ. J. Pharm. Sci.]]></source>
<year>2005</year>
<volume>4</volume>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="confpro">
<source><![CDATA[United States Pharmacopeia and National Formulary (USP 41-NF 36)]]></source>
<year></year>
<conf-name><![CDATA[ United States Pharmacopeial Convention]]></conf-name>
<conf-date>2016</conf-date>
<conf-loc> </conf-loc>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<source><![CDATA[European Pharmacopoeia]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Strasbourg ]]></publisher-loc>
<publisher-name><![CDATA[Council of Europe]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fessi]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Puisieux]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Devissaguet]]></surname>
<given-names><![CDATA[J.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Ammoury]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Benita]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nanocapsule for mation by interfacial polymer deposition following solvent displacement]]></article-title>
<source><![CDATA[Int. J. Pharm.]]></source>
<year>1989</year>
<volume>55</volume>
<page-range>R1-4</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neto]]></surname>
<given-names><![CDATA[F.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[S.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[A.J.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Lafourcade]]></surname>
<given-names><![CDATA[P.A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Sistemas poliméricos nanodispersos obtidos por encapsulação de a 6-Amirina: Processo tecnológico e utilidade farmacológica, Patent BR 10 2020 008802 5, INPI]]></source>
<year></year>
<publisher-loc><![CDATA[Brazil ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prada]]></surname>
<given-names><![CDATA[A.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[A.J.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Keita]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Zapata]]></surname>
<given-names><![CDATA[E.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[E.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cassia grandis fruit extract reduces the blood glucose level in alloxan-induced diabetic rats]]></article-title>
<source><![CDATA[Biomed. Pharmacother]]></source>
<year>2018</year>
<volume>103</volume>
<page-range>421-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[A.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Silva-Barcellos]]></surname>
<given-names><![CDATA[N.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Rezende]]></surname>
<given-names><![CDATA[B.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[E.L. de]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[J. de]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biopharmaceutics classification system: importance and inclusion in biowaiver guidance]]></article-title>
<source><![CDATA[Braz. J. Pharm. Sci]]></source>
<year>2015</year>
<volume>51</volume>
<page-range>143-55</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kranz]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Gutsche]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the drug release patterns and long-term stability of aqueous and organic coated pellets by using blends of enteric and gastrointestinal insoluble polymers]]></article-title>
<source><![CDATA[Int. J. Pharm.]]></source>
<year>2009</year>
<volume>380</volume>
<page-range>112-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maki]]></surname>
<given-names><![CDATA[M.A.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Elumalai]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ahamed]]></surname>
<given-names><![CDATA[H.N.]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[P.V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Design a lymphatic specific delivery system of rHuKGF in rat and assessment of intestinal lym phatic uptake]]></article-title>
<source><![CDATA[Biomed. Eng. Int.]]></source>
<year>2020</year>
<volume>2</volume>
<page-range>0066-74</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guadarrama-Escobar]]></surname>
<given-names><![CDATA[O. R.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Vázquez]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano-Castañeda]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Chamorro-Cevallos]]></surname>
<given-names><![CDATA[G. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Cruz]]></surname>
<given-names><![CDATA[I.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Padrón]]></surname>
<given-names><![CDATA[A.Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar-Chávez]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development, characterization, optimization, and in vivo evalu ation of methacrylic acid-ethyl acrylate copolymer nanoparticles loaded with glibenclamide in diabetic rats for oral administration]]></article-title>
<source><![CDATA[Pharmaceutics]]></source>
<year>2021</year>
<volume>13</volume>
<page-range>2023</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhukova]]></surname>
<given-names><![CDATA[O.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Arkhipova]]></surname>
<given-names><![CDATA[E.V.]]></given-names>
</name>
<name>
<surname><![CDATA[Kovaleva]]></surname>
<given-names><![CDATA[T.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ryabov]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Ivanova]]></surname>
<given-names><![CDATA[I.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Golovacheva]]></surname>
<given-names><![CDATA[A.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Zykova]]></surname>
<given-names><![CDATA[D.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Zaitsev]]></surname>
<given-names><![CDATA[S.D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunopharmacological properties of methacrylic acid polymers as potential polymeric carrier constituents of antican cer drugs]]></article-title>
<source><![CDATA[Molecules]]></source>
<year>2021</year>
<volume>26</volume>
<page-range>4855</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Castaño]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Pino]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Uribarri]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Riverón]]></surname>
<given-names><![CDATA[L. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Cedré]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Talavera]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against]]></article-title>
<source><![CDATA[Vibrio cholera, Travel Med. Infect. Dis.]]></source>
<year>2013</year>
<volume>11</volume>
<page-range>103-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
